Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer
NCT00956228
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Prostatic Neoplasm
Interventions
RADIATION:
radioimmuniguided intenstiy modulated radiotherapy
Sponsor
Mayo Clinic